Programme
Time (BST) | Time (CEST) | Topic | Speaker | Company |
Wednesday 16th September 2020 | ||||
08:45 - 09:00 | 09:45 - 10:00 | Registration | Andrew Dean | Vice-Chair, |
09:00 - 09:05 | 10:00 - 10:05 | Welcome & Introduction | Rachid BenHamza | President, |
09:05 - 09:25 | 10:05 - 10:25 | Keynote Address | Shaun Grady | Vice-President Business Development Operations, AstraZeneca |
09:25 - 09:45 | 10:25 - 10:45 | Covid-19: The First 6 Months | Andrew Dean | Director and Owner, |
09:45 - 10:05 | 10:45 - 11:05 | Biopharmaceutical Sector: Finance and Deal Making Outlook | Stephanie Leouzon | Partner and Head of Torreya Europe, |
10:05 - 10:25 | 11:05 - 11:25 | Global Pipeline Overview | Manon Decelles | Founder and Managing Director, |
Wednesday 16th September | ||||
15:30 - 15:35 | 16:30 - 16:35 | Welcome | Andrew Dean | Vice-Chair, |
15:35 - 15:55 | 16:35 - 16:55 | Translation and Entrepreneurship at the Francis Crick Institute | Barbara Domayne-Hayman | Entrepreneur in Residence, |
15:55 - 16:15 | 16:55 - 17:15 | What's Hot in Oncology Deal Making - Where is the Low Hanging Fruit? | Chris Sheldon | VP & Head Oncology Business Development, Oncology R&D, |
16:15 - 16:35 | 17:15 - 17:35 | The Application of AI in Rare Diseases | Bruce E. Bloom | Chief Collaboration Officer |
16:35 - 16:55 | 17:35 - 17:55 | Pricing and Market Access in Rare Diseases | Ravi Sodha | Owner, |
16:55 - 17:00 | 17:55 - 18:00 | Closing Remarks | Andrew Dean | Vice-Chair, |
Thursday 17th September 2020 | ||||
08:45 - 09:00 | 09:45 - 10:00 | Registration | Sharon Finch | Board Member, |
09:00 - 09:45 | 10:00 -10:45 | Building Business Development Relationships in Covid-19 Times | Chris Vaes
| Senior Director M&A and Transactions,
|
09:45 - 10:30 | 10:45 - 11:30 | Impact of Covid-19 on Promotional Activities, could Covid-19 Result in a Change to the Current Paradigm? | Lars Boerger
| Alliance Pharmaceuticals
|
10:30 - 10:35 | 11:30 - 11:35 | Closing Remarks | ||